Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

60 Degrees Pharmaceuticals Inc (SXTP)

60 Degrees Pharmaceuticals Inc (SXTP)
1.8000 x 3 1.9500 x 1
Pre-market by (Cboe BZX)
1.8750 -0.0150 (-0.79%) 04/02/25 [NASDAQ]
1.8000 x 3 1.9500 x 1
Pre-market 1.8750 unch (unch) 16:00 ET
Quote Overview for Wed, Apr 2nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.8100
Day High
1.9100
Open 1.8700
Previous Close 1.8750 1.8750
Volume 10,200 10,200
Avg Vol 31,945 31,945
Stochastic %K 42.16% 42.16%
Weighted Alpha -85.53 -85.53
5-Day Change unch (unch) unch (unch)
52-Week Range 1.4100 - 35.9940 1.4100 - 35.9940
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,784
  • Shares Outstanding, K 1,473
  • Annual Sales, $ 680 K
  • Annual Income, $ -7,950 K
  • EBIT $ -10 M
  • EBITDA $ -6 M
  • 60-Month Beta 3.39
  • Price/Sales 9.13
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.31
  • Number of Estimates 1
  • High Estimate -1.31
  • Low Estimate -1.31
  • Prior Year 1.80
  • Growth Rate Est. (year over year) -172.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4100 +33.33%
on 03/10/25
Period Open: 1.8100
2.1300 -11.74%
on 03/18/25
+0.0700 (+3.87%)
since 02/28/25
3-Month
1.4100 +33.33%
on 03/10/25
Period Open: 6.5500
8.0000 -76.50%
on 01/08/25
-4.6700 (-71.30%)
since 01/02/25
52-Week
1.4100 +33.33%
on 03/10/25
Period Open: 16.8960
35.9940 -94.78%
on 07/19/24
-15.0160 (-88.87%)
since 04/02/24

Most Recent Stories

More News
60 Degrees Pharmaceuticals Announces 2024 Annual Results

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESS Newswire / February 21, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Fathom Holdings Inc. (Nasdaq:FTHM) on the RedChip Small...

FTHM : 0.7620 (-2.31%)
SXTP : 1.8800 (-0.53%)
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

RedChat provides data-driven precision, real-time efficiency, and comprehensive coverage

BFRG : 1.6400 (-0.61%)
SXTP : 1.8800 (-0.53%)
GRRR : 20.77 (-17.35%)
CNTM : 0.7483 (+51.17%)
OSTX : 1.5100 (+13.53%)
RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

RedChat provides data-driven precision, real-time efficiency, and comprehensive coverage

BFRG : 1.6400 (-0.61%)
SXTP : 1.8800 (-0.53%)
GRRR : 20.77 (-17.35%)
CNTM : 0.7483 (+51.17%)
OSTX : 1.5100 (+13.53%)
60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. microti) Babesiosis

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
60 Degrees Pharmaceuticals Partners with Brigham and Women's Hospital for Clinical Trial Evaluating Tafenoquine in Treatment of Severe Babesiosis

The trial evaluates tafenoquine's efficacy for severe babesiosis, led by Brigham and Women’s Hospital, involving multiple clinical sites.Quiver AI Summary60 Degrees Pharmaceuticals, Inc. has announced...

SXTP : 1.8800 (-0.53%)
60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (Nasdaq:VSEE) and 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) on the RedChip Small Stocks, Big...

VSEE : 1.2000 (-0.83%)
SXTP : 1.8800 (-0.53%)
60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / November 22, 2024 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Can-Fite BioPharma Ltd. (NYSE American:CANF)(TASE:CANF) on the...

SXTP : 1.8800 (-0.53%)
CANF : 1.5200 (+8.57%)
60 Degrees Pharmaceuticals Reports 164% Year-Over-Year Increase in Q3 2024 Sales Revenue

60 Degrees Pharmaceuticals reported Q3 2024 revenue of $135,000, a 164% increase, with improved gross profit and rising expenses.Quiver AI Summary60 Degrees Pharmaceuticals, Inc. reported a significant...

SXTP : 1.8800 (-0.53%)
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch

SXTP : 1.8800 (-0.53%)
SXTPW : 0.0228 (-0.87%)

Business Summary

60 Degrees Pharmaceuticals Inc. specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. 60 Degrees Pharmaceuticals Inc. is based in WASHINGTON.

See More

Key Turning Points

3rd Resistance Point 2.0233
2nd Resistance Point 1.9667
1st Resistance Point 1.9233
Last Price 1.8800
1st Support Level 1.8233
2nd Support Level 1.7667
3rd Support Level 1.7233

See More

52-Week High 35.9940
Fibonacci 61.8% 22.7829
Fibonacci 50% 18.7020
Fibonacci 38.2% 14.6211
Last Price 1.8800
52-Week Low 1.4100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades